Moderna Vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
WEDNESDAY, MAY 25, 2022
WEDNESDAY, MAY 25, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা

Moderna Vaccine

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Moderna raises full-year Covid vaccine sales forecast to $21 billion

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Moderna to seek regulatory approval for Covid shot for very young children

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. Photo :Reuters
Coronavirus chronicle

Moderna seeks FDA authorisation for second Covid booster for all adults

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Moderna plots vaccines against 15 pathogens with future pandemic potential

FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo
Coronavirus chronicle

US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost

Vials of coronavirus disease (Covid-19) vaccines of Pfizer-BioNTech and Moderna are seen in the town of Ricany near Prague, Czech Republic, February 25, 2021. REUTERS/David W Cerny/File Photo
Covid-19 in Bangladesh

Bangladesh to get 89 lakh more doses of Pfizer, Moderna vaccines

Moderna submits application to US regulator for Covid booster shot
Coronavirus chronicle

Moderna submits application to US regulator for Covid booster shot

FILE PHOTO: Vials with a sticker reading "Covid-19/Coronavirus vaccine/Injection only" and a syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Japan finds another Moderna vial suspected to contain foreign substance

FILE PHOTO: An employee shows the Moderna coronavirus disease (Covid-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, US, December 21, 2020. REUTERS/Eduardo Munoz
Covid-19 in Bangladesh

Japan's Moderna vaccine contamination woes widen as 1mn more shots withdrawn

Two die in Japan after shots from suspended Moderna vaccines
Coronavirus chronicle

Two die in Japan after shots from suspended Moderna vaccines

Representational image. Illustration: TBS
Crime

Drugstore owner held in capital for possessing Moderna shots

Photo: REUTERS/Mike Segar
Bangladesh

Moderna vaccination kicks off in 12 city corporations

Pfizer, Moderna vaccines stop infections in real-world study
Coronavirus chronicle

Pfizer, Moderna vaccines stop infections in real-world study

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab